As coro­n­avirus vari­ants trig­ger new alarms, the NIH is putting an un­der-the-radar ‘next-gen’ vac­cine in­to PhI

Over the past year, the world has been trans­fixed by the de­vel­op­ment of new vac­cines to fight SARS-CoV-2. In a fren­zy of ac­tiv­i­ty, the new mR­NA ap­proach has de­liv­ered pi­o­neer­ing emer­gency ap­provals in record time. And with some set­backs, the more tra­di­tion­al big play­ers are com­ing along with added jabs as the most af­flu­ent na­tions in the world be­gin to vac­ci­nate large por­tions of their pop­u­la­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER